GGrantIndex
Sort

261,768 grants matching gene therapy

Antigen Specific Therapy in CNS Autoimmune Diseases

$1,361,839
Howard L Weiner · Brigham And Women'S Hospital · P01 · FY2008 · NS

Center Driven Project

$1,361,698
Stacey Gabriel · Broad Institute, Inc. · U54 · FY2010 · HG

UC Denver Diabetes Research Center

$1,361,135
Lori Sussel · University Of Colorado Denver · P30 · FY2021 · DK

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$1,361,114
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology

$1,361,099
Charles Nicholas Serhan · Brigham And Women'S Hospital · P01 · FY2012 · GM

Novel Therapeutic Strategies for PKD

$1,361,085
Mount Sinai School Of Medicine Of Nyu · P01 · FY2004 · DK

Early Biomarkers of Autism Spectrum Disorders in infants with Tuberous Sclerosis

$1,360,955
Mustafa None Sahin · Boston Children'S Hospital · U01 · FY2015 · NS

Cannabinoid CB1 and CB2 receptors and drug abuse

$1,360,939
Zheng-Xiong Xi · National Institute On Drug Abuse · ZIG · FY2020 · DA

Multi-functional anti-thrombotic therapy for coronary microvascular obstruction

$1,360,862
Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2024 · HL

Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology

$1,360,594
Charles Nicholas Serhan · Brigham And Women'S Hospital · P01 · FY2014 · GM

Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease

$1,360,328
David M Gamm · University Of Wisconsin-Madison · U19 · FY2023 · NS

Therapeutic targets and novel anticancer agents for endocrine cancers

$1,360,206
Naris Nilubol · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Prenatal Treatment of Down Syndrome to Improve Brain Development and Neurocognition

$1,360,060
Diana Bianchi · National Human Genome Research Institute · ZIA · FY2023 · HG

Neurobiology of Addiction

$1,360,000
George Koob · National Institute On Drug Abuse · ZIC · FY2017 · DA

Overcoming Immune Barriers to Gene Correction for Duchenne Muscular Dystrophy

$1,359,974
Jerry Mendell · Research Inst Nationwide Children'S Hosp · U54 · FY2011 · HD

Phase II Study of Inhales Carbon Monoxide for the Treatment of Idiopathic Pulmona

$1,359,804
Augustine M Choi · Brigham And Women'S Hospital · U01 · FY2010 · HL

Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology

$1,359,745
Charles Nicholas Serhan · Brigham And Women'S Hospital · P01 · FY2015 · GM

Transcription and Splicing Dynamics in Single Cells

$1,359,710
Daniel Larson · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Novel AAVs Engineered for Efficient and Noninvasive Cross-Species Gene Editing Throughout the Central Nervous System

$1,359,680
Benjamin E Deverman · Broad Institute, Inc. · UH3 · FY2022 · NS

Studies of Populations Exposed to Occupational Sources of Radiation

$1,359,653
Martha S Linet · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA

Mechanisms of Peripheral Induction of T-Cell Tolerance

$1,359,583
Matthew F Mescher · University Of Minnesota · P01 · FY2007 · AI

UCSF Stanford Endometriosis Center for Discovery, Innovation, Training and Community Engagement

$1,359,467
Linda C Giudice · University Of California, San Francisco · P01 · FY2024 · HD

Characterization of novel regulators of self-renewal and pluripotency

$1,359,403
Guang Hu · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES

Targeted Prevention for Non-Melanoma Skin Cancer

$1,359,369
Clara Curiel-Lewandrowski · University Of Arizona · P01 · FY2022 · CA

Oncogenic Kinases in Cancer

$1,359,286
John Brognard · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA